Antimicrobial utilisation surveillance statistics
Surveillance of antimicrobial usage is a fundamental component of antimicrobial stewardship, and is a required action of hospitals for accreditation according to the National Safety and Quality in Health Service Standard 3 (Preventing and Controlling Healthcare Associated Infections).
National Antimicrobial Utilisation Surveillance Program (NAUSP)
The National Antimicrobial Utilisation Surveillance Program (NAUSP) collects data from over 150 major Australian Hospitals and provides reports of key antibiotic usage rates on a six monthly basis.
De-identified peer group reports are submitted every six months to the Australian Commission on Safety and Quality in Health Care (ACSQHC). These show aggregated data collected from all NAUSP hospitals, principal referral hospitals and public acute group A hospitals. . Private hospitals are included within their appropriate peer group. Other reports show aggregated data at a state level and de-identified benchmarked data. De-identified reports by peer groups are also available.
Contributor hospitals can access individual usage rate reports which contain charts showing comparators made up of the average of usage at similarly peered hospitals through the NAUSP Portal since January 2017. Some contributors can access reports for Intensive Care Unit, haematology/oncology, High Dependency Unit and respiratory ward specialities.
National speciality reports are presented below, along with de-identified benchmarking reports for Intensive Care usage in Principal Referral and acute group A hospitals.
A detailed NAUSP annual report is produced showing usage of an expanded number of antimicrobials both nationally and in individual Australian public and private hospitals in a de-identified manner.
National reports by peer group - July 2016 to June 2018
Public acute group A hospitals (PDF 961KB) - formerly called Large Public Acute
National speciality reports - January 2017 to June 2018
Statewide reports - July 2016 to June 2018
Benchmarking reports - January 2018 to June 2018
The Australian Commission on Safety and Quality in Health Care provides funding for the development and coordination of NAUSP and analyses of NAUSP data and related reports for the AURA Surveillance System.
For further information on the antimicrobial utilisation surveillance program, contact the NAUSP coordinator.